Your AI-Trained Oncology Knowledge Connection!
Opinion
Video
Author(s):
Key opinion leaders discuss the patient journey, highlighting the clinical course of the disease and the corresponding imaging needs at each stage, such as identification of biopsy site, delineation of tumor, and differentiation of response from treatment-related effects.
Jun 5th 2025 - Jul 12th 2025
Jun 5th 2025 - Jul 12th 2025
Jun 5th 2025 - Jul 12th 2025
Jun 6th 2025 - Jul 12th 2025
Jun 6th 2025 - Jul 12th 2025
Jun 5th 2025 - Jul 12th 2025
Jun 5th 2025 - Jul 12th 2025
Jun 5th 2025 - Jul 12th 2025
Jun 6th 2025 - Jul 12th 2025
Jun 6th 2025 - Jul 12th 2025
Jun 5th 2025 - Jul 12th 2025
Jun 5th 2025 - Jul 12th 2025
Jun 5th 2025 - Jul 12th 2025
Dr Fathi on the Efficacy and Safety of Ziftomenib in R/R NPM1-Mutant AML
Dr Schetelig on Haploidentical vs Mismatched Transplant Efficacy in AML/ALL/MDS
Dr Dahiya on the Safety Profile of KITE-363 in Relapsed/Refractory B-Cell Lymphoma
Venetoclax/DEC-C Is Potential New SOC in Newly Diagnosed AML Ineligible for Intensive Chemo
2 Commerce Drive
Cranbury, NJ 08512